| scholarly article | Q13442814 |
| P2093 | author name string | Ashok Kumar | |
| Michael B. Reid | |||
| Rahul Malya | |||
| Aladin M. Boriek | |||
| Niraj Khandelwal | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dystrophin, muscular dystrophy | Q14864296 |
| mechanotransduction | Q11936292 | ||
| P304 | page(s) | 102–113 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | FASEB Journal | Q520194 |
| P1476 | title | Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers | |
| P478 | volume | 18 |
| Q35083651 | A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. |
| Q99581453 | Absence of Desmin in Myofibers of the Zebrafish Extraocular Muscles |
| Q33893451 | Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle |
| Q38616557 | Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age. |
| Q45069467 | Anisotropic mechanosensitive pathways in the diaphragm and their implications in muscular dystrophies |
| Q28588382 | Anisotropic regulation of Ankrd2 gene expression in skeletal muscle by mechanical stretch |
| Q24629251 | Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts |
| Q37085050 | Biology of the striated muscle dystrophin-glycoprotein complex |
| Q24241080 | Calcium antagonists for Duchenne muscular dystrophy |
| Q38761095 | Calcium signaling in skeletal muscle development, maintenance and regeneration |
| Q39010745 | Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies? |
| Q33626503 | Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice. |
| Q37827157 | Current advances in cell therapy strategies for muscular dystrophies |
| Q34600184 | Cytoplasmic gamma-actin contributes to a compensatory remodeling response in dystrophin-deficient muscle |
| Q38263986 | Desmin in muscle and associated diseases: beyond the structural function. |
| Q36501691 | Dilated cardiomyopathy: a tale of cytoskeletal proteins and beyond |
| Q37593034 | Distinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy. |
| Q26795772 | Dystrophin and the two related genetic diseases, Duchenne and Becker muscular dystrophies |
| Q37414983 | Early manifestation of alteration in cardiac function in dystrophin deficient mdx mouse using 3D CMR tagging |
| Q36977749 | Early mechanical dysfunction of the diaphragm in the muscular dystrophy with myositis (Ttnmdm) model |
| Q36095627 | Enhanced Na+/H+ exchange activity contributes to the pathogenesis of muscular dystrophy via involvement of P2 receptors |
| Q27693233 | Fluorescence-based force/tension sensors: a novel tool to visualize mechanical forces in structural proteins in live cells |
| Q36139893 | Genome-wide Mechanosensitive MicroRNA (MechanomiR) Screen Uncovers Dysregulation of Their Regulatory Networks in the mdm Mouse Model of Muscular Dystrophy |
| Q37583167 | Immune-mediated mechanisms potentially regulate the disease time-course of duchenne muscular dystrophy and provide targets for therapeutic intervention |
| Q34237002 | Impaired adaptive response to mechanical overloading in dystrophic skeletal muscle |
| Q42512800 | In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice |
| Q30592983 | In vivo single-molecule imaging identifies altered dynamics of calcium channels in dystrophin-mutant C. elegans |
| Q34509322 | Induction of Sirt1 by mechanical stretch of skeletal muscle through the early response factor EGR1 triggers an antioxidative response |
| Q36985669 | Inhibition of extracellular signal-regulated kinase 1/2 signaling has beneficial effects on skeletal muscle in a mouse model of Emery-Dreifuss muscular dystrophy caused by lamin A/C gene mutation |
| Q27438151 | Inhibitory control over Ca(2+) sparks via mechanosensitive channels is disrupted in dystrophin deficient muscle but restored by mini-dystrophin expression |
| Q38269131 | Invited review: Stem cells and muscle diseases: advances in cell therapy strategies |
| Q36691055 | L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers |
| Q33339391 | L-type Ca2+ channel function is linked to dystrophin expression in mammalian muscle |
| Q54515938 | Losartan, a therapeutic candidate in congenital muscular dystrophy: studies in the dy(2J) /dy(2J) mouse. |
| Q35774782 | Masticatory muscles of mouse do not undergo atrophy in space |
| Q33947243 | Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice |
| Q37239871 | Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy. |
| Q38165141 | Mechanical properties of respiratory muscles |
| Q35148782 | Mechanisms inducing low bone density in Duchenne muscular dystrophy in mice and humans |
| Q37158222 | Mechanotransduction gone awry |
| Q33647871 | Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle |
| Q36122457 | Micropatterning of TCR and LFA-1 ligands reveals complementary effects on cytoskeleton mechanics in T cells. |
| Q35750207 | Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice. |
| Q47643952 | NADPH oxidase mediates microtubule alterations and diaphragm dysfunction in dystrophic mice. |
| Q34490590 | Orai1 mediates exacerbated Ca(2+) entry in dystrophic skeletal muscle |
| Q35175749 | Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy |
| Q39391006 | Overview of the Muscle Cytoskeleton |
| Q39499956 | P2X7 purinoceptor alterations in dystrophic mdx mouse muscles: relationship to pathology and potential target for treatment |
| Q34163572 | PKC theta ablation improves healing in a mouse model of muscular dystrophy |
| Q37164566 | PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle |
| Q33809437 | Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy |
| Q34473309 | Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy. |
| Q36805372 | Poloxamer 188 reduces the contraction-induced force decline in lumbrical muscles from mdx mice |
| Q37447128 | Protein-DNA array-based identification of transcription factor activities differentially regulated in skeletal muscle of normal and dystrophin-deficient mdx mice. |
| Q47360059 | Regenerative capacity of the dystrophic (mdx) diaphragm after induced injury |
| Q35166254 | Role of TGF-β signaling in inherited and acquired myopathies |
| Q38623198 | Sarcolemmal damage in dystrophin deficiency is modulated by synergistic interactions between mechanical and oxidative/nitrosative stresses |
| Q95316103 | Systematic Review of Instrumented Measures of Skeletal Muscle Mechanical Properties: Evidence for the Application of Shear Wave Elastography with Children |
| Q35564107 | The danger model approach to the pathogenesis of the rheumatic diseases |
| Q98163745 | The ties that bind: functional clusters in limb-girdle muscular dystrophy |
| Q53263857 | Therapeutic effects of exon skipping and losartan on skeletal muscle of mdx mice. |
| Q38264461 | Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy |
| Q33707964 | Therapeutic targeting of signaling pathways in muscular dystrophy |
| Q33591765 | Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization |
| Q81657096 | Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle |
| Q36678229 | Unloaded speed of shortening in voltage-clamped intact skeletal muscle fibers from wt, mdx, and transgenic minidystrophin mice using a novel high-speed acquisition system. |
| Q42386051 | Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation |
| Q31015982 | Use of imaging biomarkers to assess perfusion and glucose metabolism in the skeletal muscle of dystrophic mice |
| Q35847178 | Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances |
| Q37138490 | Wasting mechanisms in muscular dystrophy. |
| Q42524932 | l-Glutamine administration reduces oxidized glutathione and MAP kinase signaling in dystrophic muscle of mdx mice |
Search more.